MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity

Michael Hollis, Kavitha Nair, Arpita Vyas, Lakshmi Shankar Chaturvedi, Sahil Gambhir, Dinesh Vyas

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Abstract

Over the past decade, research has shown that aberrant expression of microRNA (miRNA) is involved in colorectal cancer development and progression. MicroRNAs are small sequences of non-coding RNA that regulate expression of genes involved in important cellular functions, such as cell differentiation, multiplication, and apoptosis. A specific miRNA may display the effects of a tumor suppressor or oncogene. Altered miRNA expression is found in colorectal cancer (CRC) and patterns of miRNA expression correlate with CRC detection and outcome. Studies also have examined the use of circulating serum miRNA and fecal miRNA expression as non-invasive markers for early detection. Here, we review recent evidence demonstrating the potential role of miRNA in CRC and the implications of its use in the diagnosis, prognosis, and management of CRC.

Original languageEnglish
Pages (from-to)8284-8292
Number of pages9
JournalWorld Journal of Gastroenterology
Volume21
Issue number27
DOIs
StatePublished - Jul 21 2015

Keywords

  • Colorectal cancer
  • Diagnostic
  • Expression
  • Fecal microRNA
  • Microrna
  • Prognostic
  • Serum microRNA
  • Therapeutic

Fingerprint

Dive into the research topics of 'MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity'. Together they form a unique fingerprint.

Cite this